Back to Results
First PageMeta Content
International AIDS Society / IAS Conference on HIV Pathogenesis / Treatment and Prevention / HIV / AIDS / Elizabeth Glaser Pediatric AIDS Foundation / HIV/AIDS in China / HIV Clinical Resource / Health / HIV/AIDS / Medicine


PRESS RELEASE IAS Welcomes Janssen to CIPHER program Collaboration to support advances in pediatric HIV treatment and care in low-resource settings GENEVA, Switzerland, December[removed] — As part of its continued commi
Add to Reading List

Document Date: 2014-12-11 08:17:32

Open Document

File Size: 321,30 KB

Share Result on Facebook

City

GENEVA / Durban / Vancouver / /

Company

Janssen Pharmaceutical Companies / Johnson & Johnson / Johnson & Johnson The Janssen Pharmaceutical Companies / ViiV Healthcare’s Paediatric Innovation Seed Fund / Janssen / /

Country

Switzerland / Canada / South Africa / /

Event

Business Partnership / /

IndustryTerm

HIV treatment / healthcare stakeholders / healthcare solutions / clinical management / pharmaceutical / /

MedicalCondition

inflammatory bowel disease / HIV / schizophrenia / multiple myeloma / dementia / epidemic / rheumatoid arthritis / cardiovascular and metabolic diseases / diabetes / Hepatitis C / pain / AIDS / HIV/AIDS / psoriasis / prostate cancer / infectious disease / tuberculosis / /

Organization

New Horizons / International AIDS Society / Paediatric Innovation Seed Fund / UNAIDS / Elizabeth Glaser Pediatric AIDS Foundation / /

Person

Perry Mohammed / Marissa Vicari / /

Position

custodian / CIPHER Project Manager / integral player / /

ProvinceOrState

British Columbia / /

Technology

neuroscience / /

URL

www.iasociety.org / www.janssen.com / www.ias2015.org / www.aids2016.org / /

SocialTag